PubRank

J Temsamani

Author PubWeight™ 24.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A protein that specifically recognizes the 3' splice site of mammalian pre-mRNA introns is associated with a small nuclear ribonucleoprotein. Cell 1986 4.57
2 Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci U S A 1991 2.76
3 Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem 2005 2.14
4 Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity. Nucleic Acids Res 1993 1.53
5 Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects. Clin Pharmacol Ther 1995 1.34
6 New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol Pharmacol 2000 1.32
7 Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokinet 1995 1.23
8 Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acid Drug Dev 1997 1.08
9 Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem Pharmacol 1996 1.04
10 Doxorubicin-peptide conjugates overcome multidrug resistance. Anticancer Drugs 2001 0.99
11 Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. Biochemistry 2001 0.97
12 Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. J Pharmacol Exp Ther 2001 0.97
13 Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice. Antisense Nucleic Acid Drug Dev 1998 0.97
14 Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. Eur J Biochem 2001 0.96
15 Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery. Antisense Res Dev 1995 0.83
16 Comparison of in vitro transcriptions using various types of DNA templates. Anal Biochem 1993 0.81
17 Purified U5 small nuclear ribonucleoprotein can relieve the inhibition of spliceosome assembly and splicing by snRNP-free nuclear proteins. Nucleic Acids Res 1989 0.81
18 Interplay between U2 snRNP and 3' splice factor(s) for branch point selection on human beta-globin pre-mRNA. Nucleic Acids Res 1990 0.76
19 [Antisense oligonucleotides: a new therapeutic approach]. Pathol Biol (Paris) 1998 0.75
20 Modulation of oligonucleotide-induced immune stimulation by cyclodextrin analogs. Biochem Pharmacol 1996 0.75
21 Comparative pharmacokinetics of antisense oligonucleotides. Methods Mol Med 1996 0.75